| Application no. and date | 99944294.0 (espacenet) (Federated) (European Patent Register), 19990726 | | Patent/reg. no. and date | DK/EP 1100829, 20070905 | | Publication date | 20010523 | | Priority no. and date | GB 9816281, 19980727, GB 9912460, 19990527 | | EP pub. no. and date |
EP 1100829 20010523 | | Effective date | | | Applicant/owner | UNIVERSITY COLLEGE LONDON, Rowland Hill Street
London NW3 2PF, GB,
Novartis AG, Lichtstrasse 35
4056 Basel, CH | | Applicant ref. no. | 130946 | | Inventor | AMLOT, Peter, Lloyd, 270 Ferme Park Road
London N8 9BL, GB,
SCHREIER, Max, H., Oberwilerstrasse 50
CH-4054 Basel, CH | | Representative | Budde Schou A/S, Dronningens Tværgade 30, 1302 København K | | Opponent | | | IPC Class | A61K 39/395 (2006.01) , C07K 16/28 (2006.01) | | Title | Anvendelse af basiliximab til behandling af rheumatoid arthritis eller hudsygdomme | | Int. application no. | EP1999005316 | | Int. publication no. | WO2000006604 | | Related patent (certificate) | | | Status | Udløbet | | Pædiatrisk forlængelse | - | | Udløbsdato for pædiatrisk forlængelse | - |
|
